This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
August 22, 2018
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2018
August 20, 2018
Vicore Pharmas acquisition of INIM Pharma completed
August 16, 2018
MIPS INTERIM REPORT JANUARY – JUNE 2018
August 16, 2018
Nexstim Plc Half-Yearly Report 1 January – 30 June 2018 (unaudited)
August 16, 2018
BONESUPPORT – CERAMENT® G Approved by Health Canada
August 15, 2018
Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
August 15, 2018
Strongbridge Biopharma plc Announces Termination of Public Offering of Ordinary Shares
August 14, 2018
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
August 10, 2018
MIPS: Invitation to the presentation of the results for the period January – June 2018
August 09, 2018
Notice of Nexstim Plc’s Half-Yearly Report H1 2018